Management of sexual dysfunction due to antipsychotic drug therapy (Q24246362)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Management of sexual dysfunction due to antipsychotic drug therapy (English)

0 references

1 reference

3

0 references

author name string

Michael M Berner

series ordinal

1

0 references

Mathias Hagen

series ordinal

2

0 references

Hussein Omar

series ordinal

4

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Low-dose imipramine for thioridazine-induced male orgasmic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Sildenafil use in patients with olanzapine-induced erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Sexual dysfunction in women using major tranquilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Effects of risperidone on gonadal axis hormones in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Switch to quetiapine in antipsychotic agent-related hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Prolactin levels and adverse events in patients treated with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Haloperidol-induced impotence improved by switching to olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Psychotropic drug-induced sexual function disorders: diagnosis, incidence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Burden of phase-specific sexual dysfunction with SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Sexual dysfunction with psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Sexual dysfunction in the United States: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

A Survey of Sexual Side Effects Among Severely Mentally Ill Patients Taking Psychotropic Medications: Impact on Compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

A survey of psychosexual arousability in male patients on depot neuroleptic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

A Systematic Review of Research on Strategies for the Management of Antipsychotic-Induced Sexual Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

Sexual disorders in nonacute psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

Sildenafil citrate (Viagra) treatment of sexual dysfunction in a schizophrenic patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003546.PUB2

7 January 2021

10.1002/14651858.CD003546.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4225565

4225565

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference